Skip to main content

FDA recall, , Moderate risk

Philips Brilliance iCT and Spectral CT Scanners

Spectral CT 7500 on Rails may have fasteners not torqued to specification, potentially causing rotor parts to become unsecured and expelled.

What happened

Philips North America Llc, of Cambridge, Massachusetts, recalled Brilliance iCT, Spectral CT, IQon Spectral CT, and Spectral CT 7500 on Rails systems because one or more of the thirty-two fasteners attaching the rotor to the bearing within the gantry may not be torqued to specification, which could cause the rotor or rotor parts to become unsecured or displaced.

The recall began January 7, 2026, and was added to the FDA's Enforcement Report on February 6, 2026. The systems were distributed nationwide in 24 states and internationally in the countries listed in the notice.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

4 products

Affected if its UDI-DI is listed.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Brilliance iCT; Product Code (REF): 728306;

    UDI-DI
    • 00884838059474
  2. Spectral CT; Product Code (REF): 728333;

    UDI-DI
    • 00884838101111
  3. IQon Spectral CT; Product Code (REF): 728332;

    UDI-DI
    • 00884838059542
  4. Spectral CT 7500 on Rails; Product Code (REF): 728334;

    UDI-DI
    • 00884838103627

Recall details

Company began the recall
Sold in

Worldwide - US Nationwide distribution in the states of Alabama, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Illinois, Indiana, Kentucky, Louisiana, Massachusetts, Maryland, Minnesota, North Carolina, New York, Ohio, Oregon, Pennsylvania, Texas, Vermont, Washington, West Virginia and the countries of Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Chile, China, Costa Rica, Croatia, Czech Republic, Denmark, Ecuador, Egypt, El Salvador, France, Germany, Hong Kong, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kuwait, Lithuania, Macao, Mexico, Netherlands, New Zealand, Norway, Panama, Philippines, Poland, Portugal, R¿union, Russian Fed., Saudi Arabia, Serbia, Singapore, South Africa, South Korea, Spain, Switzerland, Taiwan, Thailand, Turkmenistan, United Kingdom, Uzbekistan, Vietnam.

Company
Philips North America LlcCambridge, Massachusetts
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98248
Recall numbers
Z-1315-2026 to Z-1318-2026

All recalls from Philips North America Llc

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)